Accretion Pharmaceuticals Limited (NSE:ACCPL)
India · Delayed Price · Currency is INR 193.20
+3.20 (1.68%)
At close: Oct 13, 2026
Accretion Pharmaceuticals Market Cap
Accretion Pharmaceuticals has a market cap or net worth of 2.15 billion as of October 16, 2026. It is the 36,131st most valuable company in the world and the 2,660th biggest in India. Its market cap has increased by 229.13% in one year.
Market Cap
2.15B
Enterprise Value
2.23B
Revenue
896.27M
Global Rank
Country Rank
#2,660 India
PE Ratio
21.40
ChartMarket Cap Chart
Since May 21, 2025, Accretion Pharmaceuticals's market cap has increased from 922.07M to 2.15B, an increase of 132.91%. That is a compound annual growth rate of 83.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 2.15B | 119.92% |
| Dec 31, 2025 | 976.54M | 5.91% |
| May 21, 2025 | 922.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BDH Industries | 2.53B |
| Bilcare | 2.24B |
| Everest Organics | 2.21B |
| Gennex Laboratories | 2.19B |
| Sanjivani Paranteral | 2.14B |
| Sat Kartar Life | 2.10B |
| Bio Medica Laboratories | 2.07B |
| Coral Laboratories | 1.91B |